
|Articles|October 1, 2003
FDA SUPPORTS GENENTECH PSORIASIS DRUG
An advisory board to the Food and Drug Administration was unanimous in recommending the approval of Raptiva, a psoriasis drug manufactured by Genentech.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Allergan Aesthetics Refreshes APP Loyalty Program for Aesthetic Practices
5










